NIH-funded research R01 grant

Mitochondria and IL-13 in eosinophilic esophagitis

Official title: Mitochondria in eosinophilic esophagitis pathogenesis

Funded at Temple Univ of the Commonwealth · NIH-11349699 · Data updated 2026-11-12

A study exploring how immune signals and mitochondria interact in eosinophilic esophagitis to find new biomarkers and targets for treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 15, 2024
Project endMay 31, 2028
Funding year2026
Award (this year)$679,490
NIH project number5R01DK136987-03
Project IDNIH-11349699 on NIH RePORTER

Who could benefit from this research

Could help

Patients with eosinophilic esophagitis or those undergoing evaluation for EoE.

Less likely to help

Individuals without EoE or related esophageal conditions may not benefit directly.

What this research studies

Eosinophilic esophagitis is a chronic, immune-driven condition that causes ongoing esophageal inflammation. The researchers will focus on how the immune molecule IL-13 changes mitochondria inside esophageal cells and whether these changes drive tissue remodeling and inflammation. They will test molecular pathways (like JAK/STAT signaling) and see if reducing mitochondrial changes can lessen disease features. They also plan to examine mitochondrial alterations as potential biomarkers in patients with EoE. The work combines cell-based studies with analysis that could translate to human patients.

Why it matters

Potential benefit: If successful, the project could identify new biomarkers and therapeutic targets to better diagnose and treat EoE.

How similar studies have gone: Prior work has linked IL-13 and mitochondrial dynamics to tissue remodeling, but this project tests a specific IL-13–mitochondria mechanism in EoE.

Where this research is happening

  • Temple Univ of the Commonwealth
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Whelan, Kelly a — Temple Univ of the Commonwealth
  • Study coordinator: Whelan, Kelly a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.